Transpek Industry FY26 Profit Falls; Q4 EBITDA Margin Contracts to 11.96%
Transpek Industry reported a decline in FY26 consolidated net profit to ₹4,564.54 lakh from ₹4,873.70 lakh, with revenue from operations falling to ₹6,211.99 crore from ₹6,498.53 crore. Q4 performance was notably weak, with EBITDA contracting to ₹177M from ₹322M YoY and EBITDA margin narrowing to 11.96% from 19.50%. The Board recommended a ₹20 per share dividend and fixed the AGM for September 15, 2026.

*this image is generated using AI for illustrative purposes only.
Transpek Industry Limited reported a decline in consolidated net profit for the financial year ended March 31, 2026, while its Board of Directors recommended a dividend of ₹20 per equity share. The company recorded a consolidated net profit of ₹4,564.54 lakh for FY26, compared to ₹4,873.70 lakh in the previous year. Revenue from operations for the year stood at ₹6,211.99 crore, down from ₹6,498.53 crore in FY25. The Board approved the audited financial results for the quarter and year ended March 31, 2026, during its meeting on May 26, 2026.
The statutory auditor, Bansi S. Mehta & Co., provided an unmodified opinion on the standalone and consolidated financial results, confirming compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors confirmed that the statements present a true and fair view in conformity with Indian Accounting Standards. The consolidated financial results incorporate data from Transpek Creative Chemistry Private Limited, a wholly owned subsidiary.
Q4 Performance: Profitability Under Pressure
For the quarter ended March 31, 2026, Transpek Industry's operational profitability deteriorated sharply on a year-on-year basis. Q4 EBITDA declined to ₹177M from ₹322M in the same period last year, while the EBITDA margin contracted significantly to 11.96% from 19.50% YoY. On a standalone basis, Q4 net profit fell to ₹66M from ₹193M YoY, and Q4 revenue came in at ₹1.5B compared to ₹1.65B in the corresponding period. On a consolidated basis, the company reported a net profit of ₹658.03 lakh for the quarter, a decrease from ₹1,925.13 lakh in the same period last year, with consolidated revenue at ₹1,482.15 crore versus ₹1,652.57 crore in Q4FY25. Total expenses for the quarter amounted to ₹1,436.55 crore.
The following table summarises the key Q4 metrics on a year-on-year basis:
| Metric: | Q4 FY26 | Q4 FY25 |
|---|---|---|
| EBITDA: | ₹177M | ₹322M |
| EBITDA Margin: | 11.96% | 19.50% |
| Standalone Net Profit: | ₹66M | ₹193M |
| Revenue: | ₹1.5B | ₹1.65B |
| Consolidated Net Profit: | ₹658.03 lakh | ₹1,925.13 lakh |
| Consolidated Revenue: | ₹1,482.15 crore | ₹1,652.57 crore |
Dividend and AGM Details
The Board has fixed the Annual General Meeting for September 15, 2026, at 3.00 p.m. via video conferencing. The recommended dividend of ₹20 per share, amounting to 200% of the face value of ₹10, is subject to shareholder approval at the AGM. If approved, the dividend will be paid within 30 days of the declaration. The company's earnings per share (EPS) for the year stood at ₹81.72 on a consolidated basis, down from ₹87.25 in the previous year. The trading window, which had been closed since April 1, 2026, is set to reopen on May 28, 2026.
Financial Summary for FY26
The table below presents the key annual financial metrics for FY26 on both a standalone and consolidated basis:
| Metric: | Standalone FY26 (₹ in Lakhs) | Consolidated FY26 (₹ in Lakhs) |
|---|---|---|
| Revenue from Operations: | 62,119.90 | 62,119.90 |
| Total Income: | 64,570.34 | 64,570.34 |
| Total Expenses: | 58,450.62 | 58,450.89 |
| Net Profit for the period: | 4,564.81 | 4,564.54 |
| Earnings Per Share (Basic): | 81.73 | 81.72 |
Historical Stock Returns for Transpek Industry
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -10.42% | -12.41% | -7.14% | -5.91% | -5.91% | -5.91% |
What specific factors led to the sharp decline in Q4 EBITDA margins, and are these pressures expected to persist into the next financial year?
How will the company balance the recommended dividend payout with the observed decline in annual net profit and earnings per share?
What strategic initiatives does Transpek Industry plan to implement to reverse the trend of falling revenue and operational profitability?


































